Q32 Bio Inc.
QTTBNasdaqCIK 1661998HealthcareFiscal year ends Dec 31
Reports and events: 130 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-3013:20 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-408435 |
| 2026-09-1411:15 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-389836 |
| 2026-08-0511:09 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-333831 |
| 2026-08-0511:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-333813 |
| 2026-07-2001:32 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000947871-26-000713 |
| 2026-07-1521:18 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-304964 |
| 2026-07-1312:39 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-301520 |
| 2026-07-1311:09 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-301464 |
| 2026-06-1620:01 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-272562 |
| 2026-06-0101:10 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000947871-26-000592 |
| 2026-05-2820:28 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001628098-26-000005 |
| 2026-05-2720:01 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-241846 |
| 2026-05-0621:48 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000947871-26-000500 |
| 2026-05-0511:14 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-205021 |
| 2026-05-0511:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-205006 |
| 2026-04-3011:02 ET | DEF 14A | Proxy statementPeriod 2026-06-12 | 0001193125-26-193934 |
| 2026-04-2420:09 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-177178 |
| 2026-03-2721:15 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-129431 |
| 2026-03-1221:06 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000947871-26-000245 |
| 2026-03-1011:14 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-099339 |
| 2026-03-1011:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-099328 |
| 2026-02-1721:18 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-054711 |
| 2025-12-1921:06 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-326821 |
| 2025-12-0112:14 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-303115 |
| 2025-11-1312:09 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-278812 |
| 2025-11-1312:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-278805 |
| 2025-10-2111:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-244262 |
| 2025-08-0611:08 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-103530 |
| 2025-08-0611:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-103526 |
| 2025-06-2512:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-146179 |
| 2025-06-1720:02 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-25-142039 |
| 2025-05-2311:00 ET | 8-K | 3.01 Delisting notice | 0001193125-25-125435 |
| 2025-05-0811:11 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-066371 |
| 2025-05-0811:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-066366 |
| 2025-04-2911:10 ET | DEF 14A | Proxy statementPeriod 2025-06-13 | 0000950170-25-059558 |
| 2025-04-2520:02 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-096703 |
| 2025-03-1111:18 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-036823 |
| 2025-03-1111:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-036819 |
| 2025-03-1011:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-050372 |
| 2025-02-1021:14 ET | 8-K | 2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-017075 |
| 2025-01-1312:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-004976 |
| 2024-12-1112:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-274856 |
| 2024-11-0712:16 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-122785 |
| 2024-11-0712:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-122770 |
| 2024-08-0811:10 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-093305 |
| 2024-08-0811:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-093295 |
| 2024-07-0911:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-082307 |
| 2024-05-0911:18 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-056273 |
| 2024-05-0911:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-056256 |
| 2024-04-1920:03 ET | S-1 | Registration statement | 0001193125-24-102858 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.